Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report

MINH DUNG NGUYEN, OLENA GOROBETS, YANNICK JOEL DJOUA, JOHAN ROSE-DITE-MODESTINE, VINCENT VINH-HUNG, CLAIRE VERSCHRAEGEN and NAM P. NGUYEN
Anticancer Research June 2025, 45 (6) 2535-2538; DOI: https://doi.org/10.21873/anticanres.17625
MINH DUNG NGUYEN
1King’s College Hospital, London, U.K.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nguyenmdmd{at}gmail.com
OLENA GOROBETS
2Cancer Tech Care Association, Perpignan, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YANNICK JOEL DJOUA
3Service d’Urologie, Hopital Mangot Vulcin, Le Lamentin, Martinique, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHAN ROSE-DITE-MODESTINE
3Service d’Urologie, Hopital Mangot Vulcin, Le Lamentin, Martinique, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VINCENT VINH-HUNG
4Centre Hospitalier Public du Cotentin, Cherbourg-en-Cotentin, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLAIRE VERSCHRAEGEN
5The Ohio State University Comprehensive Cancer Center, Columbus, OH, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NAM P. NGUYEN
6Department of Radiation Oncology, Howard University, Washington, DC, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 45 no. 6 2535-2538
DOI 
https://doi.org/10.21873/anticanres.17625
PMID 
40425347

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 4, 2025
  • Revision received May 13, 2025
  • Accepted May 14, 2025
  • Published online May 27, 2025.

Copyright & Usage 
Copyright © 2025 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. MINH DUNG NGUYEN1⇑,
  2. OLENA GOROBETS2,
  3. YANNICK JOEL DJOUA3,
  4. JOHAN ROSE-DITE-MODESTINE3,
  5. VINCENT VINH-HUNG4,
  6. CLAIRE VERSCHRAEGEN5 and
  7. NAM P. NGUYEN6
  1. 1King’s College Hospital, London, U.K.;
  2. 2Cancer Tech Care Association, Perpignan, France;
  3. 3Service d’Urologie, Hopital Mangot Vulcin, Le Lamentin, Martinique, France;
  4. 4Centre Hospitalier Public du Cotentin, Cherbourg-en-Cotentin, France;
  5. 5The Ohio State University Comprehensive Cancer Center, Columbus, OH, U.S.A.;
  6. 6Department of Radiation Oncology, Howard University, Washington, DC, U.S.A.
  1. Minh Dung Nguyen, King’s College Hospital, Denmark Hill, London SE5 9RS, U.K. Tel: +44 7934477050, e-mail: nguyenmdmd{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 45 (6)
Anticancer Research
Vol. 45, Issue 6
June 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report
MINH DUNG NGUYEN, OLENA GOROBETS, YANNICK JOEL DJOUA, JOHAN ROSE-DITE-MODESTINE, VINCENT VINH-HUNG, CLAIRE VERSCHRAEGEN, NAM P. NGUYEN
Anticancer Research Jun 2025, 45 (6) 2535-2538; DOI: 10.21873/anticanres.17625

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report
MINH DUNG NGUYEN, OLENA GOROBETS, YANNICK JOEL DJOUA, JOHAN ROSE-DITE-MODESTINE, VINCENT VINH-HUNG, CLAIRE VERSCHRAEGEN, NAM P. NGUYEN
Anticancer Research Jun 2025, 45 (6) 2535-2538; DOI: 10.21873/anticanres.17625
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Case Report
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving Pembrolizumab
  • Delayed Initiation of Postoperative S-1 Adjuvant Chemotherapy Worsens Prognosis After Gastric Cancer Recurrence
  • Clinical Outcomes of the Optimized Weekly 8-Gy Palliative Radiotherapy Regimen
Show more Clinical Studies

Keywords

  • Androgen deprivation
  • end of life
  • enzalutamide
  • Elderly
  • index case
  • toxicity
  • treatment duration
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire